European Multidisciplinary Conference in Thoracic Oncology, Lugano 09

Teaming up to catch the winds of change in thoracic oncology
The European Society for Medical Oncology (ESMO), the European Society for Therapeutic Radiology and Oncology (ESTRO), the European Society of Thoracic Surgeons (ESTS) and the European Respiratory Society (ERS) have identified the need to cooperate in the education of healthcare professionals treating malignant chest tumors.
Teaming up to catch the winds of change in thoracic oncology  Show

 
A regular multidisciplinary, educational meeting on this topic is considered important for strengthening general knowledge and providing an updated overview of prevention, screening, diagnosis, treatment modalities and results of translational research. This Conference facilitates interaction between the specialities in order to promote an integrated approach to diagnosis and treatment of chest tumors and to strengthen European cooperation and scientific exchange in multidisciplinary management of lung cancer.
   Show

Official Welcome

 [+]  Webcast ESMO
R. Stahel (Zurich, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast City of Lugano
A. Jelmini (Lugano, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast ESMO Scientific Committee
R. Pirker (Vienna, Austria)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Keynote lecture

 [+]  Webcast Milestones in the management of lung cancer
R. Stahel (Zurich, Switzerland)
5
Read or add comments and rate material  
    Bookmark this material     Share or cite
5
Read or add comments and rate material  
    Bookmark this material     Share or cite

WHO Keynote lecture

 [+]  Webcast A thousand seconds, a thousand lives
B. Zolty (Geneva, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Lung cancer biology: Clinical implications

 [+]  Webcast New findings in the molecular biology of lung cancer: clinical application
D. Gandara (Sacramento, USA)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast Prognostic factors in non-small cell lung cancer
P. O'Byrne (Dublin, Ireland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast Predictive factors in NSCLC
E. Felip (Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast Clinical trials based on biomarkers
R. Rosell (Barcelona, Spain)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Diagnosis and staging

 [+]  Webcast 10 Invasive staging
P. De Leyn (Leuven, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 11 Individualised staging: practical implications
S. Spiro (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

01.05.2009

NSCLC stage III

 [+]  Webcast 18 Heterogeneity of stage III and its implication on treatment
R. M. Huber (Munich, Germany)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 19 Surgery
W. Weder (Zurich, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 20 New developments in radiotherapy
R. Dziadziuszko (Gdansk, Poland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

NSCLC Stage IV. Treatment standards and new developments

 [+]  Webcast 21 First-line therapy
P. Kosmidis (Athens, Greece)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 22 Second line therapy for advanced non-small cell lung cancer
M. Cullen (Birmingham, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 23 Surgery in selected cases
W. Klepetko (Wien, Austria)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 24 Will stereotactic body radiotherapy prolong survival in patients with stage IV NSCLC?
P. Baumann (Stockholm, Sweden)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Neuroendocrine tumors, mesothelioma and thymoma

 [+]  Webcast 25 Small cell lung cancer
J-P. Sculier (Brussels, Belgium)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 26 Other neuroendocrine tumors
E. Lim (London, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 27 Tumors of the thymus
F. Venuta (Rome, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

02.05.2009

Individualised therapy based on tumor features

 [+]  Webcast 28 Challenges and limitations of individualised therapy
M. Taron (Lugano, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Elderly and co-morbid patients

 [+]  Webcast 29 Radiotherapy
C. Faivre-Finn (Manchester, United Kingdom)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 30 Systemic treatment
C. Gridelli (Avellino, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

European treatment guidelines

 [+]  Webcast 31 ESMO clinical recommendations - NSCLC
G. D'Addario (Schaffhausen, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 32 European treatment guidelines: small cell lung cancer (SCLC)
J. Soerensen (Copenhagen, Denmark)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 33 European treatment guidelines: mesothelioma
R. Stahel (Zurich, Switzerland)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite

Future developments in multidisciplinary treatments: where are we going?

 [+]  Webcast 34 Radiotherapy for stage III non-small cell lung cancer (NSCLC)
D. De Ruysscher (Maastricht, The Netherlands)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
 [+]  Webcast 35 NSCLC stage IV
L. Crino (Perugia, Italy)
0
Read or add comments and rate material  
    Bookmark this material     Share or cite
0
Read or add comments and rate material  
    Bookmark this material     Share or cite